Recent progress in pediatric stem cell transplantation

Kimikazu Matsumoto, Koji Kato

Research output: Contribution to journalReview article

Abstract

Pediatric hematopoietic stem cell transplantation (SCT) has been well established. Recent advances in the transplantation conditioning regimens and in the stem cell sources allow us to increase the candidates for transplantation, but the actual number of pediatric SCTs has been decreased because of the decline in the pediatric population and the progress of various chemotherapies and molecular targeted therapies. Pediatric SCT has become rather sophisticated. Cord blood (CB) stem cell transplantation has the problem of rejection and high relapse rate in the advanced malignant diseases. To overcome the rejection and relapse, it is important to select CB with a large number of the cells and the HLA-mismatched CB. Reduced intensity preparative regimens are increasingly adopted to reduce the early and late transplantation-related complications. In the pediatric setting, reduced intensity transplantation is still under investigation. Late complications for pediatric SCT, growth failure and secondary malignancies should be considered for the increasing number of long-term survivors.

Original languageEnglish
Pages (from-to)187-193
Number of pages7
JournalGan to kagaku ryoho. Cancer & chemotherapy
Volume34
Issue number2
Publication statusPublished - Jan 1 2007
Externally publishedYes

Fingerprint

Stem Cell Transplantation
Pediatrics
Transplantation
Fetal Blood
Cord Blood Stem Cell Transplantation
Transplantation Conditioning
Molecular Targeted Therapy
Recurrence
Hematopoietic Stem Cell Transplantation
Survivors
Stem Cells
Cell Count
Drug Therapy
Growth
Population
Neoplasms

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Recent progress in pediatric stem cell transplantation. / Matsumoto, Kimikazu; Kato, Koji.

In: Gan to kagaku ryoho. Cancer & chemotherapy, Vol. 34, No. 2, 01.01.2007, p. 187-193.

Research output: Contribution to journalReview article

@article{6e45583e29df4c569635bcddb70f05e9,
title = "Recent progress in pediatric stem cell transplantation",
abstract = "Pediatric hematopoietic stem cell transplantation (SCT) has been well established. Recent advances in the transplantation conditioning regimens and in the stem cell sources allow us to increase the candidates for transplantation, but the actual number of pediatric SCTs has been decreased because of the decline in the pediatric population and the progress of various chemotherapies and molecular targeted therapies. Pediatric SCT has become rather sophisticated. Cord blood (CB) stem cell transplantation has the problem of rejection and high relapse rate in the advanced malignant diseases. To overcome the rejection and relapse, it is important to select CB with a large number of the cells and the HLA-mismatched CB. Reduced intensity preparative regimens are increasingly adopted to reduce the early and late transplantation-related complications. In the pediatric setting, reduced intensity transplantation is still under investigation. Late complications for pediatric SCT, growth failure and secondary malignancies should be considered for the increasing number of long-term survivors.",
author = "Kimikazu Matsumoto and Koji Kato",
year = "2007",
month = "1",
day = "1",
language = "English",
volume = "34",
pages = "187--193",
journal = "Japanese Journal of Cancer and Chemotherapy",
issn = "0385-0684",
publisher = "Japanese Journal of Cancer and Chemotherapy Publishers Inc.",
number = "2",

}

TY - JOUR

T1 - Recent progress in pediatric stem cell transplantation

AU - Matsumoto, Kimikazu

AU - Kato, Koji

PY - 2007/1/1

Y1 - 2007/1/1

N2 - Pediatric hematopoietic stem cell transplantation (SCT) has been well established. Recent advances in the transplantation conditioning regimens and in the stem cell sources allow us to increase the candidates for transplantation, but the actual number of pediatric SCTs has been decreased because of the decline in the pediatric population and the progress of various chemotherapies and molecular targeted therapies. Pediatric SCT has become rather sophisticated. Cord blood (CB) stem cell transplantation has the problem of rejection and high relapse rate in the advanced malignant diseases. To overcome the rejection and relapse, it is important to select CB with a large number of the cells and the HLA-mismatched CB. Reduced intensity preparative regimens are increasingly adopted to reduce the early and late transplantation-related complications. In the pediatric setting, reduced intensity transplantation is still under investigation. Late complications for pediatric SCT, growth failure and secondary malignancies should be considered for the increasing number of long-term survivors.

AB - Pediatric hematopoietic stem cell transplantation (SCT) has been well established. Recent advances in the transplantation conditioning regimens and in the stem cell sources allow us to increase the candidates for transplantation, but the actual number of pediatric SCTs has been decreased because of the decline in the pediatric population and the progress of various chemotherapies and molecular targeted therapies. Pediatric SCT has become rather sophisticated. Cord blood (CB) stem cell transplantation has the problem of rejection and high relapse rate in the advanced malignant diseases. To overcome the rejection and relapse, it is important to select CB with a large number of the cells and the HLA-mismatched CB. Reduced intensity preparative regimens are increasingly adopted to reduce the early and late transplantation-related complications. In the pediatric setting, reduced intensity transplantation is still under investigation. Late complications for pediatric SCT, growth failure and secondary malignancies should be considered for the increasing number of long-term survivors.

UR - http://www.scopus.com/inward/record.url?scp=33947515952&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33947515952&partnerID=8YFLogxK

M3 - Review article

C2 - 17301525

AN - SCOPUS:33947515952

VL - 34

SP - 187

EP - 193

JO - Japanese Journal of Cancer and Chemotherapy

JF - Japanese Journal of Cancer and Chemotherapy

SN - 0385-0684

IS - 2

ER -